A new approach for enhancing differential selectivity of drugs to cancer cells.

Abstract

The degree to which anticancer agents selectively target cancer cells is a key determinant in successful therapeutic outcomes. Inhibitors of the Hsp90 molecular chaperone represent an important new class of anticancer agents. We propose here a novel mechanism by which physiochemical properties of Hsp90 inhibitors can be optimized to increase selectivity… (More)

Topics

  • Presentations referencing similar topics